Vical

Vical gets $1 million payment from partner Merck

Biotechnology company Vical Inc. said Monday it received a $1 million milestone payment from partner Merck & Co. after that company decided to start an early stage study on a potential cancer vaccine.

BRIEF-Vical receives milestone payment from Merck & Co., Inc

Interactive Investor brings you breaking news throughout the day to support your investment decisions. You can also filter by category. BRIEF-Vical receives milestone payment from Merck & Co., Inc. Dec 1 (Reuters) - Vical Inc:...

Rates on Treasury bills at all-time lows

The Treasury Department auctioned $28 billion in three-month bills at a discount rate of 0.150 percent, unchanged from last week, which was the lowest on record. Another $28 billion in six-month bills was auctioned at a...

Vical Announces Strategic Restructuring and Staff Reduction (PR Newswire)

Vical Incorporated today announced a strategic restructuring including a staff reduction of 29 employees, approximately 20% of the company's total workforce, and accelerated closure of a research facility.

InPlay: Novartis AG's Sandoz receives positive EU opinion for biosimilar filgrastim (Briefing.com)

7:54AM AnnTaylor misses by $0.01, reports revs in-line 5.35 : Reports Q3 (Oct) net of breakeven, $0.01 worse than the First Call consensus of $0.01; revenues fell 12.3% year/year to $527.2 mln vs the $531.9 mln consensus....

Hepatitis C Therapeutic DNA Vaccine Delivered By Inovio Biomedical's Electroporation Technology...

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported positive additional interim results...

Vical Executive Alain Rolland Named AAPS Fellow (PR Newswire)

Vical Incorporated today announced that Alain P. Rolland, Pharm.D., Ph.D., the company's Senior Vice President, Product Development, was named a Fellow of the American Association of Pharmaceutical Scientists .

Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial

PRNEWSWIRE SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Vical Incorporated announced today that the company has completed enrollment of subjects in a Phase 2 trial of its therapeutic DNA vaccine designed to prevent...

Stockguru.com: Stocks to Watch for November 11, 2008 - BJCT, OCTL, UGNE, OLGX, BVTI, and AXSI

Our Stocks to Watch today include : Bioject Medical Technologies Inc. (OTCBB: BJCT), Octillion Corp. (OTCBB: OCTL), Unigene Laboratories, Inc. (OTCBB: UGNE), Osteologix, Inc. (OTCBB: OLGX), Biovest International, Inc. (OTCBB:...

InPlay: Huntsman misses by $0.11, beats on revs (Briefing.com)

13.85 : Co reports October same store sales of +4%. 7:41AM Warnaco Group misses by $0.10, beats on revs; guides FY08 EPS below consensus 25.63 : Reports Q3 (Sep) earnings of $0.62 per share, $0.10 worse than the First Call...

1 2 next